Table 1.
Subjects with hypertension and prescribed treatment
| Group | Total | Hypertensive Subjects | Hydro-chlorothiazide | ACE Inhibitor | Beta blocker | Calcium channel blockers | Angiotensin II receptor antagonist | Alpha adrenergic blocker |
|---|---|---|---|---|---|---|---|---|
| O-HC | 10 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| O-STOPP | 23 | 10 | 7 | 4 | 1 | 1 | 2 | 0 |
| O-START | 10 | 4 | 2 | 1 | 0 | 1 | 0 | 2 |
| V-POTS | 11 | 3 | 0 | 1 | 0 | 2 | 0 | 0 |
| V-STOPP | 32 | 10 | 3 | 6 | 1 | 3 | 0 | 1 |
| V-START | 14 | 4 | 1 | 2 | 2 | 0 | 0 | 0 |
| Total | 100 | 32 | 13 | 14 | 4 | 7 | 2 | 4 |
32 subjects had a confirmed diagnosis of hypertension during history and physical examination. Eleven subjects were on a combination-drug regimen with the most common prescription being Hydrochlorothiazide/Lisinopril (n=6).